Urticarial eruption in coronavirus disease 2019 infection: a case report in Tangerang, Indonesia

Gunawan, C.; Aramburo, Angela; Widysanto, Allen

doi:10.1111/jdv.16622

Cited by 24 publications

(30 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Another report from Indonesia described a 51-year-old patient who suddenly developed a generalized pruritic urticarial rash 3 days posthospitalization for COVID-19–related pneumonia. 4 A Spanish study describing urticarial lesions in a COVID-19–positive patient did not find any difference between “common urticaria” and COVID-19–related urticaria on histologic examination. 5 …”

Section: Discussionmentioning

confidence: 93%

Angioedema and urticaria in a COVID-19 patient: A case report and review of the literature

2020

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 93%

Angioedema and urticaria in a COVID-19 patient: A case report and review of the literature

2020

View full text Add to dashboard Cite

“…Near submission day, rerun of the literature for possible new case reports having dermatological manifestations was done. They also reported similar cutaneous manifestations 53,60‐72 . Initial studies on cutaneous manifestations of COVID‐19 were predominantly from China, Europe, and USA.…”

Section: Discussionmentioning

confidence: 74%

The trend of cutaneous lesions during COVID‐19 pandemic: lessons from a meta‐analysis and systematic review

2020

View full text Add to dashboard Cite

Background Besides predominant respiratory and gastrointestinal manifestations, reports on cutaneous manifestations in COVID-19 patients are being noted increasingly. Objectives To estimate the prevalence of cutaneous manifestations in COVID-19 patients. Methods This study was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. A detailed literature search was done in PubMed and Embase from December 1, 2019, till May 1, 2020. Studies reporting cutaneous manifestations in COVID-19 patients were included. Irrespective of the heterogeneity of data, a random effects model with inverse-variance approach was used for pooling the prevalence using meta package in R version 3.6.2. Results Out of 15,143 articles, 2086 articles were selected for full-text read. Forty-three articles were selected for qualitative analysis, of which 10 articles (N = 1682) were included for meta-analysis. The pooled prevalence of overall cutaneous lesions was 5.69 (95% confidence interval [CI]: 1.87-15.98; I 2 88%). The pooled prevalence of other outcome parameters were as follows: viral exanthem-like presentation 4.15 (95% CI: 1.33-12.23; I 2 88%), maculopapular rash 3.81 (95% CI: 1.02-13.18; I 2 87%), vesiculobullous lesions 1.67 (95% CI: 0.70-3.96; I 2 0%). Conclusion The estimated prevalence of cutaneous manifestations in COVID-19 was 5.69%. Other manifestations were urticaria, chilblain-like lesions, livedo reticularis, and finger/toe gangrene. Although it is premature to conclude the prevalence of the cutaneous manifestations during this ongoing pandemic, our report may be a stimulating factor for the physicians to perform further vigilant streamlined reporting of cutaneous manifestations in COVID-19 patients to estimate the final prevalence. Epidermal cytopathic changes: ballooning or reticular degeneration of keratinocytes, dyskeratotic keratinocytes, and epidermal giant cells; Interface dermatitis: band-like or nodular inflammatory infiltrate involving papillary dermis and basement membrane with or without apoptosis or vacuolation of basal

show abstract

“…After eliminating the overlaps between the two search engines, we were left with 23 works investigating the relationships between SARS-CoV-2 infection and urticaria. Of these, 18 reported cases of urticaria in patients with SARS-CoV-2 infection [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37]. Unfortunately, not all studies reported the characteristics of the patients studied (gender, age, timing, etc.)…”

Section: Resultsmentioning

confidence: 99%

Urticaria and coronavirus infection a lesson from SARS-CoV-2 pandemic

Allegra

Asero

Giovannetti

et al. 2021

Eur Ann Allergy Clin Immunol

View full text Add to dashboard Cite

Urticaria is a condition involving both skin and mucosal tissues characterized by the presence of wheals and/or angioedema. The acute form has been related to allergic reactions to drugs or foods, interaction with chemicals, or infections. We reviewed the association of urticaria with coronavirus infections. This review was carried out by the use of two search engines for published original articles, employing two key terms correlated to urticaria and viruses: "urticaria" and one term linked to each virus. The research of the relationships between SARS-CoV-2 and urticaria produced 18 papers (including a total of 114 cases. Surprisingly, the search for cases of urticaria in patients with SARS-CoV or MERS produced no results. We tried to interpret this discrepancy and attempted to analyze the possible pathogenesis of urticaria lesions in SARS-CoV-2.

show abstract

Urticarial eruption in coronavirus disease 2019 infection: a case report in Tangerang, Indonesia

Abstract: Figure 2 Urticaria involving face, on the right side (a) and left side of the face (b).

Cited by 24 publications

References 11 publications

Angioedema and urticaria in a COVID-19 patient: A case report and review of the literature

Angioedema and urticaria in a COVID-19 patient: A case report and review of the literature

The trend of cutaneous lesions during COVID‐19 pandemic: lessons from a meta‐analysis and systematic review

Urticaria and coronavirus infection a lesson from SARS-CoV-2 pandemic

Contact Info

Product

Resources

About